Sonnet BioTherapeutics Holdings, Inc. (SONN)
Dec 2, 2025 - SONN was delisted (reason: merged into PURR)
1.260
-1.840 (-59.35%)
Inactive · Last trade price on Dec 2, 2025

SONN Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
94573535
Market Cap Growth
242.32%-13.25%-30.09%-79.64%0.50%-
Enterprise Value
81-222932
Last Close Price
1.266.6922.92258.721493.186332.48
PS Ratio
3.41233.5833.9320.5072.86-
PB Ratio
--8.96-22.19-2.831.5811.61
P/TBV Ratio
----1.5811.61
EV/Sales Ratio
8.3550.81-6.3560.68-
Debt / Equity Ratio
-0.02-0.27-0.90-0.100.010.12
Asset Turnover
0.260.010.030.020.03-
Quick Ratio
0.180.280.550.464.121.56
Current Ratio
0.260.660.860.664.301.62
Return on Equity (ROE)
----301.42%-197.66%-27822.18%
Return on Assets (ROA)
-223.80%-180.62%-208.63%-106.50%-84.78%-270.89%
Return on Invested Capital (ROIC)
----184.48%-121.74%-2921.10%
Return on Capital Employed (ROCE)
461.50%2698.20%19757.40%1270.70%-112.50%-532.50%
Earnings Yield
-157.59%-170.95%-375.53%-414.34%-70.90%-69.20%
FCF Yield
-119.86%-197.85%-425.56%-387.18%-64.01%-44.75%
Buyback Yield / Dilution
-469.85%-404.96%-425.71%---
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q